Diagnostics

NEW YORK  — Private health insurance claim lines with a type 2 diabetes diagnosis more than doubled in the pediatric population (ages 0 to 22 years) from 2011 to 2015, increasing 109%, according to data from FAIR Health, a national, independent, nonprofit organization dedicated to bringing transparency to healthcare costs and health insurance information.

STANFORD, Calif.  — The future of wearables may not only be in self-care, where users collect health data points to help guide their lifestyle choices, but also as a diagnostic tool to diagnose disease earlier in its cycle, according to a study released by Stanford University School of Medicine Thursday.

Wearable sensors that monitor heart rate, activity, skin temperature and other variables can reveal a lot about what is going on inside a person, including the onset of infection, inflammation and even insulin resistance, according the researchers.

LAS VEGAS  — Omron Healthcare last week unveiled its next generation prototype, Project Zero 2.0 – an ultra-compact, wearable wrist device that measures blood pressure with clinical accuracy and tracks other heart health data such as sleep patterns – at the CES Digital Health Summit here.

LAS VEGAS  — Dave Challis, RB VP innovation, is bringing RB's Healthier Tomorrow Challenge to CES through Indiegogo in an effort to bring to bear RB's industry expertise, business connections and mentorship to the kind of technology innovators eager to create the next industry disruptor.

LAS VEGAS  — A&D Medical is set to feature its new line of ULTRACONNECT blood pressure monitors at the CES exhibit, the company announced Wednesday. On display in A&D Medical's special CES Exhibit Suite, the new upper arm and wrist smart blood pressure monitors represent the ongoing expansion of the company's WellnessConnected product platform.

LAS VEGAS  — EarlySense on Tuesday announced it has created the first contact-free consumer health monitor capable of providing accurate information to users, their families and their caregivers on heart, breathing cycles, stress and sleep indicators.

CHESTERBROOK, Pa. — LifeScan, part of the Johnson & Johnson Diabetes Care Companies, earlier this week announced the U.S. Food and Drug Administration has cleared the wireless integration of the OneTouch Verio Flex blood glucose monitoring system with WellDoc's clinically validated diabetes management platform, BlueStar, creating a unique digital health solution for people living with Type 2 diabetes.